NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

It is my belief that you will have answers to all your questions after the UK approval.

BTW, there is no chance that DCVax can be superseded. Why? Take a look at three BPs: Roche, BMS, and Merck. Tens of billions of dollars R&D and acquisitions. In the end, all they can do is switching the injection mode from IV to subcutaneous. I believe Abbive which earned $200b from Humira must have tried hard to find a new substitute without success.